I have my sources just like many others in the know. Do you think Dr. DVH being a "paid " CELG consultant would put more or less motivation for him to work with another biotech? Kind of conflict of interest I would think. And when I said leftovers it was used loosely hence the "so to speak" phrase. What I was getting at is the criteria to be eligible for pmcb dream trials are not favorable. I don't see many fitting the requirements but if pmcb does manage to snag one or two they would be patients that have been given everything else and are failing so what the hell give them to pmcb.
News 
Market Data 
Discover 
AI
